This week, the EUDA hosted the Belgian National Drug Commissioner, Ine Van Wymersch, during her two-day visit to Lisbon. Ms Van Wymersch was accompanied by Deputy Commissioner Fabien Gerard and other members of the Belgian National Drug Commission.
During the visit, on 3 June, the delegation received an in-depth overview of the agency’s work. EUDA Executive Director Alexis Goosdeel presented the agency’s new mandate and its current state of implementation. EUDA experts followed, with briefings on key areas of the agency’s activity, including drug markets, crime and precursors, prison-related…
Read more
Rapid shifts in Europe's drug market are creating new health and security risks and challenging the region's capacity to respond. This warning comes from the European Union Drugs Agency (EUDA) in its European Drug Report 2025: Trends and Developments, released today (1). Based on data from 29 countries (EU-27, Norway and Türkiye), this annual review highlights latest trends and emerging threats.
Now in its 30th edition, the report provides evidence to inform drug policy and practice. It shows how Europe's drug market continues to evolve, with both suppliers and consumers adapting to…
Read more
Today, the EUDA launches its first Consolidated Annual Activity Report, which captures its key achievements in 2024. This was a year unlike any other, which saw the official establishment of the EUDA on 2 July 2024, succeeding the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). This marked the start of a new mission to strengthen EU preparedness on drugs. The report…
Read more
